No Data
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.
Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.
Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know
Weight-loss Drugmakers' Stocks Get a Boost From New Biden Proposal on Drug Coverage, but Will It Hold Up?
Today's Pre-Market Movers and Top Ratings | PSTX, LLY, KSS, BBY and More
